Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

649

Participants

Timeline

Start Date

February 28, 1994

Primary Completion Date

March 31, 1999

Study Completion Date

March 31, 1999

Conditions
Infant, NewbornInfant, Low Birth WeightInfant, Small for Gestational AgeInfant, PrematureRetinopathy of PrematurityBlindness
Interventions
PROCEDURE

Supplemental Oxygen Management

Supplemental arm with pulse oximetry targeted at 96% to 99% saturation, for at least 2 weeks, and until both eyes were at study endpoints.

PROCEDURE

Conventional Oxygen Management

Conventional oxygen arm with pulse oximetry targeted at 89% to 94% saturation.

Trial Locations (9)

30303

Emory University, Atlanta

38163

University of Tennessee, Memphis

45267

Cincinnati Children's Medical Center, Cincinnati

46202

Indiana University, Indianapolis

48201

Wayne State University, Detroit

75235

University of Texas Southwestern Medical Center at Dallas, Dallas

94304

Stanford University, Palo Alto

06504

Yale University, New Haven

02905

Brown University, Women & Infants Hospital of Rhode Island, Providence

All Listed Sponsors
collaborator

National Center for Research Resources (NCRR)

NIH

collaborator

National Eye Institute (NEI)

NIH

collaborator

National Institute of Nursing Research (NINR)

NIH

collaborator

Delta Gamma Sorority

UNKNOWN

collaborator

Rhea and Raymond White

UNKNOWN

collaborator

Research to Prevent Blindness

OTHER

lead

NICHD Neonatal Research Network

NETWORK